LMDXF:Ord/LumiraDx Ltd - Stock Price Quote and Dividend Data

LMDXF STOCK PRICE LATEST CLOSE

< $0.01

EXCHANGE

OTCBB

LMDXF

Ord/LumiraDx Ltd Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
LMDXF

Ord/LumiraDx Ltd Stock Price Information

LMDXF Stock Price Latest Close< $0.01
52-Week Low/High Stock Price$0.00 - $0.31
Percent Held by Institutions21.26%
Revenue$147,519,000
Net Income$-387,771,000
Cash Flow$-156,783,000
EPS-0.16%
Market Cap$450,290
Issue TypeCommon, ordinary, ADR, etc.
PE Ratio0
PE Ratio to Industry36%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry1.76%
Total Return Last 12 Months-94.12%
Total Return Last 3 Years-99.89%
Total Return Last 5 Years0.00%
Latest Trade DateOct. 25, 2024
LMDXF

Ord/LumiraDx Ltd Annual Stock Dividends

No Data available for Payment History.

LMDXF

Ord/LumiraDx Ltd Dividend Payment History

No dividends retrieved for LMDXF
LMDXF

Ord/LumiraDx Ltd Other Dividend Details

LumiraDx is a point of care diagnostic company. Co.'s existing test menu includes its International Normalized Ratio test for monitoring warfarin therapy, its Glycated Hemoglobin test for monitoring diabetes, its NT-proBNP test for aiding in the diagnosis of heart failure, its D-Dimer test for aiding in diagnosis and exclusion of venous thromboembolism, and its C-Reactive Protein test which measures a universal biomarker of infection and inflammation. Co. has developed four rapid COVID-19 molecular reagent testing kits for use on open molecular systems, SARS-CoV-2 RNA STAR, SARS-CoV-2 RNA STAR Complete, SARS-CoV-2 & Flu A/B RNA STAR Complete and Dual-Target SARS CoV-2 STAR Complete.

Web Sitewww.lumiradx.com
SectorHealth Care
SegmentHealth Care Services
IndustryDiagnostic & Health Related Services
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Ord/LumiraDx Ltd Dividend Stock News and Updates

Oct. 26, 2024LMDXF STOCK PRICE INCREASE: Ord/LumiraDx Ltd on 10-26-2024 increased stock price > 10% from $0.00 to $0.01

Oct. 23, 2024LMDXF STOCK PRICE DECREASE: Ord/LumiraDx Ltd on 10-23-2024 decreased stock price > 10% from $0.01 to $0.00

Oct. 22, 2024LMDXF STOCK PRICE INCREASE: Ord/LumiraDx Ltd on 10-22-2024 increased stock price > 10% from $0.00 to $0.01

Oct. 18, 2024LMDXF STOCK PRICE DECREASE: Ord/LumiraDx Ltd on 10-18-2024 decreased stock price > 10% from $0.01 to $0.00

Oct. 15, 2024LMDXF STOCK PRICE INCREASE: Ord/LumiraDx Ltd on 10-15-2024 increased stock price > 10% from $0.00 to $0.01

Sep. 28, 2024LMDXF STOCK PRICE DECREASE: Ord/LumiraDx Ltd on 09-28-2024 decreased stock price > 10% from $0.01 to $0.00

Sep. 27, 2024LMDXF STOCK PRICE INCREASE: Ord/LumiraDx Ltd on 09-27-2024 increased stock price > 10% from $0.00 to $0.01

Aug. 21, 2024LMDXF STOCK PRICE DECREASE: Ord/LumiraDx Ltd on 08-21-2024 decreased stock price > 10% from $0.01 to $0.00

Aug. 14, 2024LMDXF STOCK PRICE INCREASE: Ord/LumiraDx Ltd on 08-14-2024 increased stock price > 10% from $0.00 to $0.01

Aug. 13, 2024LMDXF STOCK PRICE DECREASE: Ord/LumiraDx Ltd on 08-13-2024 decreased stock price > 10% from $0.01 to $0.00

More Ord/LumiraDx Ltd Dividend News
Diagnostic & Health Related Services Dividend Stock News and Updates

Apr. 10, 2025MEHCQ STOCK PRICE DECREASE: 23andMe Holding Co on 04-10-2025 decreased stock price > 10% from $1.22 to $1.04

Apr. 10, 2025NYMXF STOCK PRICE DECREASE: Ord/Nymox Pharmaceutical Corp on 04-10-2025 decreased stock price > 10% from $0.14 to $0.11

Apr. 10, 2025ATIP STOCK PRICE DECREASE: Cl A/ATI Physical Therapy Inc on 04-10-2025 decreased stock price > 10% from $1.05 to $0.92

Apr. 10, 2025TALKW STOCK PRICE DECREASE: Wt Exp 06/21/2025/Talkspace Inc on 04-10-2025 decreased stock price > 10% from $0.12 to $0.09

Apr. 10, 2025CLIFF STOCK PRICE DECREASE: Cordlife Group Ltd on 04-10-2025 decreased stock price > 10% from $0.12 to $0.10

Apr. 10, 2025NEOG STOCK PRICE DECREASE: Neogen Corp on 04-10-2025 decreased stock price > 10% from $7.04 to $5.02

Apr. 10, 2025NUTX STOCK PRICE INCREASE: Com No Par/Nutex Health Inc on 04-10-2025 increased stock price > 10% from $84.94 to $103.79

Apr. 10, 2025GRAL STOCK PRICE INCREASE: GRAIL Inc on 04-10-2025 increased stock price > 10% from $21.39 to $24.90

Apr. 10, 2025BTSG STOCK PRICE INCREASE: BrightSpring Health Services Inc on 04-10-2025 increased stock price > 10% from $16.39 to $18.14

Apr. 10, 2025VVOS STOCK PRICE INCREASE: Vivos Therapeutics Inc on 04-10-2025 increased stock price > 10% from $2.23 to $2.48

More Diagnostic & Health Related Services Dividend News
X
Search Dividend Investor